Vical (VICL) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-6.2M
Depreciation and amortization	836K
Compensation expense related to stock options and awards
Receivables and other
Other assets
Accounts payable, accrued expenses and other liabilities	65K
Deferred revenue	-138K
Deferred rent	-416K
Net cash used in operating activities
Maturities of marketable securities - including restricted
Purchases of marketable securities - including restricted
Purchases of property and equipment	-230K
Patent expenditures	0
Net cash used in investing activities
Net proceeds from issuance of common stock	7.76M
Payment of withholding taxes for net settlement of restricted stock units	-13K
Net cash (used in) provided by financing activities
Net decrease in cash and cash equivalents	-4.99M
Cash and cash equivalents at beginning of period	13.45M
Cash and cash equivalents at end of period	8.46M

Entities mentioned with VICL

View All Entities